Koninklijke Philips (PHG) Liabilities and Shareholders Equity (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Liabilities and Shareholders Equity of $31.0 billion for Q2 2026, up 3.94% year-over-year from $29.9 billion in Q2 2025, and down 2.77% quarter-over-quarter from $31.9 billion in Q1 2026.
Koninklijke Philips (PHG) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Koninklijke Philips' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $31.0 billion for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity rose 3.94% year-over-year to $31.0 billion; the TTM figure through Jun 2026 stood at $125.1 billion (up 39.95% YoY), while the FY2025 annual figure was $31.4 billion, up 1.29% from the prior year.
- Liabilities and Shareholders Equity for Q2 2026 stood at $31.0 billion, down from $31.9 billion in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $34.7 billion in Q2 2022, with the low at $28.6 billion in Q1 2025.
- The 5-year median for Liabilities and Shareholders Equity is $31.3 billion (2022), against an average of $31.3 billion.
- The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity declined 11.6% in 2022, then gained 11.71% in 2026.
- Koninklijke Philips' Liabilities and Shareholders Equity stood at $31.3 billion in 2022, then advanced by 1.05% to $31.6 billion in 2023, then fell by 2.13% to $31.0 billion in 2024, then rose by 1.29% to $31.4 billion in 2025, then fell by 1.05% to $31.0 billion in 2026.
- Business Quant data shows PHG's Liabilities and Shareholders Equity at $31.0 billion in Q2 2026, $31.9 billion in Q1 2026, and $31.4 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | 22.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.04 Bn |
| Mar 31, 2026 | 31.92 Bn |
| Dec 31, 2025 | 31.36 Bn |
| Sep 30, 2025 | 30.79 Bn |
| Jun 30, 2025 | 29.86 Bn |
| Mar 31, 2025 | 28.58 Bn |
| Dec 31, 2024 | 30.96 Bn |
| Jun 30, 2024 | 31.74 Bn |
| Dec 31, 2023 | 31.64 Bn |
| Jun 30, 2023 | 32.13 Bn |
| Dec 31, 2022 | 31.31 Bn |
| Jun 30, 2022 | 34.67 Bn |
| Dec 31, 2021 | 35.42 Bn |
| Jun 30, 2021 | 34.93 Bn |
| Dec 31, 2020 | 33.04 Bn |
| Jun 30, 2020 | 30.27 Bn |
| Dec 31, 2019 | 29.90 Bn |
| Jun 30, 2019 | 29.61 Bn |
| Dec 31, 2018 | 29.70 Bn |
| Jun 30, 2018 | 29.63 Bn |